27 June 2024 - We are at a turning point in understanding the science that is opening doors to rare disease ...
30 May 2024 - The US FDA plans to release a draft guidance this year on the use of artificial intelligence/machine ...
31 May 2023 - The US FDA on Friday released an updated draft guidance to help sponsors demonstrate efficacy for ...
1 June 2023 - The price setting provisions in the Inflation Reduction Act acutely impact the research and development (R&D) ...
9 February 2023 - As antibiotic resistance increases globally, antibiotic innovation is struggling. The WHO states that the antibiotic clinical pipeline ...
9 February 2023 - Science, medicine, health care, and paying for medicines featured prominently in President Joe Biden’s State of ...
6 February 2023 - Regulators in the European Union have taken several initiatives in the past four years to increase the ...
4 November 2022 - The US FDA laid out its recommendations for sponsors to study multiple versions of a cellular or ...
29 September 2022 - EMA is launching a pilot to support the translation of basic research developments into medicines that could ...
3 February 2022 - The European Union's drug regulator said on Thursday it would support a filing for approval of ...
23 November 2021 - In 2019, longtime pharmaceutical industry critic, Peter Bach, took to the Wall Street Journal to declare that ...
15 October 2021 - Debate over the viability of the current commercial research and development model is on-going. ...
23 September 2021 - Instead of relying on price regulation, Canada should engage in negotiations about drug pricing. ...
26 April 2021 - Recent draft guidance from the US FDA addresses the non-clinical safety data to support investigational new ...
18 April 2021 - A Garvan Institute cancer researcher says the government needs to attract big pharmaceutical companies to Australia ...